Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Patent
1993-02-25
1997-08-05
Guzo, David
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
4353201, 435357, C12N 510, C12N 1586
Patent
active
056541872
ABSTRACT:
Existing plasmids, such as pHaMDR/A (available from NIH) are large and cumbersome. The size may limit the known utility of MDR1 as an effective selectable marker in gene transfer experiments. The invention provides novel plasmids including heterologous promoters and cDNA sequences positioned between the retroviral LTRs.
REFERENCES:
Miller et al., "Improved Retroviral Vectors for Gene Transfer and Expression", BioTechniques, vol. 7, No. 9 (1989) pp. 980-990.
Germann et al. "Retroviral Transfer of a Chimeric Multidrug Resistance-Adenosine Deaminase Gene", FASEB Journal, vol. 4, Mar. 1990, pp. 1501-1507.
Kane et al., "A New Vector Using the Human Multidrug Resistance Gene as a Selectable Marker Enables Overexpression of Foreign Genes in Eukaryotic Cells" Gene, vol. 84, 1989, pp. 439-446.
Guzo David
The United States of America as represented by the Department of
LandOfFree
MDR1 retroviral plasmid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with MDR1 retroviral plasmid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MDR1 retroviral plasmid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1074307